BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/06/2016

FDA Classifies Nasolacrimal Compression Device as Class I Device

The FDA has classified the nasolacrimal compression device as a Class I device, which provides a reasonable assurance of safety and effectiveness, allowing it to be marketed with general controls in place.

Source: Federal Register — Food and Drug AdministrationOpen original release →